Serena Gasperini

2.4k total citations
64 papers, 880 citations indexed

About

Serena Gasperini is a scholar working on Physiology, Rheumatology and Clinical Biochemistry. According to data from OpenAlex, Serena Gasperini has authored 64 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Physiology, 24 papers in Rheumatology and 23 papers in Clinical Biochemistry. Recurrent topics in Serena Gasperini's work include Lysosomal Storage Disorders Research (28 papers), Metabolism and Genetic Disorders (23 papers) and Glycogen Storage Diseases and Myoclonus (18 papers). Serena Gasperini is often cited by papers focused on Lysosomal Storage Disorders Research (28 papers), Metabolism and Genetic Disorders (23 papers) and Glycogen Storage Diseases and Myoclonus (18 papers). Serena Gasperini collaborates with scholars based in Italy, United States and United Kingdom. Serena Gasperini's co-authors include Maria Alice Donati, Giancarlo Parenti, Rossella Parini, Andrea Biondi, Attilio Rovelli, Simona Fecarotta, Bruno Bembi, Carmelo Rizzari, Amelia Morrone and Erica Brivio and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and International Journal of Molecular Sciences.

In The Last Decade

Serena Gasperini

57 papers receiving 873 citations

Peers

Serena Gasperini

PHYSI

RHEUM

EPIDE

Shuan-Pei Lin Taiwan

Pranoot Tanpaiboon United States

Alexander Broomfield United Kingdom

Esmée Oussoren Netherlands

Agnieszka Jurecka Poland

Carolina Fischinger Moura de Souza Brazil

Müge Güçsavaş‐Çalıkoğlu United States

Simona Fecarotta Italy

Fatih Süheyl Ezgü Türkiye

J. E. Wraith United Kingdom

Shuan-Pei Lin Taiwan

Serena Gasperini

371 ×0.8

PHYSI

206 ×0.7

RHEUM

239 ×1.1

122 ×0.7

210 ×1.4

EPIDE

Citations per year, relative to Serena Gasperini Serena Gasperini (= 1×) peers Shuan-Pei Lin

Countries citing papers authored by Serena Gasperini

Since Specialization

Citations

This map shows the geographic impact of Serena Gasperini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Gasperini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Gasperini more than expected).

Fields of papers citing papers by Serena Gasperini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Gasperini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Gasperini. The network helps show where Serena Gasperini may publish in the future.

Co-authorship network of co-authors of Serena Gasperini

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Gasperini. A scholar is included among the top collaborators of Serena Gasperini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Gasperini. Serena Gasperini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burlina, Alessandro P., Anna Ardissone, Alberto Burlina, et al.. (2025). Arginase 1 deficiency: a treatable form of spastic paraplegia. Neurological Sciences. 46(9). 4219–4228. 2 indexed citations

Fiumara, Agata, Serena Gasperini, Michele Sacchini, et al.. (2024). Avalglucosidase alfa in infantile-onset Pompe disease: A snapshot of real-world experience in Italy. Molecular Genetics and Metabolism Reports. 40. 101126–101126. 1 indexed citations

Bani, Marco, Selena Russo, Serena Gasperini, et al.. (2024). Prevalence and predictors of parental distress at the communication of positivity at newborn screening for metabolic diseases: an Italian longitudinal study. BMJ Paediatrics Open. 8(1). e003103–e003103.

Falchetti, Alberto, Sabrina Corbetta, Maria Luisa Bianchi, et al.. (2024). Glycogen Storage Disease Type I and Bone: Clinical and Cellular Characterization. Calcified Tissue International. 115(5). 661–672. 1 indexed citations

Gasperini, Serena, et al.. (2024). The Impact of Diet on Body Composition in a Cohort of Pediatric and Adult Patients with Maple Syrup Urine Disease. Nutrients. 16(18). 3145–3145.

Foiadelli, Thomas, et al.. (2023). Treatment Dilemma in Children with Late-Onset Pompe Disease. Genes. 14(2). 362–362. 4 indexed citations

Burlina, Alberto, Serena Gasperini, Giancarlo la Marca, et al.. (2023). Long-Term Management of Patients with Mild Urea Cycle Disorders Identified through the Newborn Screening: An Expert Opinion for Clinical Practice. Nutrients. 16(1). 13–13. 1 indexed citations

Toscano, António, Olimpia Musumeci, Michele Sacchini, et al.. (2023). Safety outcomes and patients’ preferences for home-based intravenous enzyme replacement therapy (ERT) in pompe disease and mucopolysaccharidosis type I (MPS I) disorder: COVID-19 and beyond. Orphanet Journal of Rare Diseases. 18(1). 338–338. 2 indexed citations

Iascone, Maria, Luigina Spaccini, Davide Tonduti, et al.. (2022). Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child. Genes. 13(3). 442–442. 14 indexed citations

10.

Pontesilli, Silvia, Cristina Baldoli, Pasquale Anthony Della Rosa, et al.. (2021). Evidence of Treatment Benefits in Patients with Mucopolysaccharidosis Type I-Hurler in Long-term Follow-up Using a New Magnetic Resonance Imaging Scoring System. The Journal of Pediatrics. 240. 297–301.e5. 1 indexed citations

11.

Laurentis, Camilla de, et al.. (2020). Cerebellar tumour-like aggregate of glycosaminoglycans in a MPS IIIB patient: a case report. Child s Nervous System. 36(9). 2093–2097.

12.

Fecarotta, Simona, Serena Gasperini, & Giancarlo Parenti. (2018). New treatments for the mucopolysaccharidoses: from pathophysiology to therapy. The Italian Journal of Pediatrics/Italian journal of pediatrics. 44(S2). 124–124. 38 indexed citations

13.

Caciotti, Anna, Matthew Mort, D.N. Cooper, et al.. (2018). Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease. BMC Medical Genetics. 19(1). 183–183. 15 indexed citations

14.

Barone, Rita, et al.. (2018). Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses. The Italian Journal of Pediatrics/Italian journal of pediatrics. 44(S2). 121–121. 31 indexed citations

15.

Wijburg, Frits A., Chester B. Whitley, Joseph Muenzer, et al.. (2018). Intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A: A phase IIb randomized trial. Molecular Genetics and Metabolism. 126(2). 121–130. 37 indexed citations

16.

Lavoratti, Giancarlo, et al.. (2011). Hemolytic uremic syndrome and rhabdomyolysis in a patient with succinate coenzyme Q reductase (complex II) deficiency. Clinical Nephrology. 76(7). 68–73. 9 indexed citations

17.

Stagi, Stefano, et al.. (2010). Autoimmune Thyroiditis, Pernicious Anaemia, Vitiligo and Scleroatrophic Lichen in a Boy with Short-Chain AcylCoA Dehydrogenase Deficiency. Hormone Research in Paediatrics. 73(5). 409–413. 2 indexed citations

18.

Cavicchi, Catia, Sabrina Malvagia, Giancarlo la Marca, et al.. (2009). Hypocitrullinemia in expanded newborn screening by LC–MS/MS is not a reliable marker for ornithine transcarbamylase deficiency. Journal of Pharmaceutical and Biomedical Analysis. 49(5). 1292–1295. 33 indexed citations

19.

Bembi, Bruno, Cesare Danesino, Maria Alice Donati, et al.. (2008). Diagnosis of glycogenosis type II. Neurology. 71(23_suppl_2). S4–11. 75 indexed citations

20.

Bembi, Bruno, Cesare Danesino, Maria Alice Donati, et al.. (2008). Management and treatment of glycogenosis type II. Neurology. 71(23_suppl_2). S12–36. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact